Free Trial

Vaxcyte (PCVX) Short Interest Ratio & Short Volume

Vaxcyte logo
$34.51 +1.35 (+4.07%)
As of 04/24/2025 04:00 PM Eastern

Vaxcyte Short Interest Data

Vaxcyte (PCVX) has a short interest of 12.05 million shares, representing 9.98% of the float (the number of shares available for trading by the public). This marks a -4.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.6, indicating that it would take 6.6 days of the average trading volume of 1.23 million shares to cover all short positions.

Current Short Interest
12,050,000 shares
Previous Short Interest
12,610,000 shares
Change Vs. Previous Month
-4.44%
Dollar Volume Sold Short
$455.01 million
Short Interest Ratio
6.6 Days to Cover
Last Record Date
March 31, 2025
Outstanding Shares
128,939,000 shares
Short Percent of Float
9.98%
Today's Trading Volume
1,180,382 shares
Average Trading Volume
1,227,024 shares
Today's Volume Vs. Average
96%
Short Selling Vaxcyte?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Vaxcyte and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PCVX Short Interest Over Time

PCVX Days to Cover Over Time

PCVX Percentage of Float Shorted Over Time

Vaxcyte Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202512,050,000 shares $455.01 million -4.4%10.0%6.6 $37.76
3/15/202512,610,000 shares $937.81 million +2.3%10.4%10.9 $74.37
2/28/202512,330,000 shares $900.34 million -7.5%10.2%10.7 $73.02
2/15/202513,330,000 shares $1.12 billion -1.5%11.0%12 $84.00
1/31/202513,530,000 shares $1.19 billion -6.6%N/A10.3 $88.32
1/15/202514,490,000 shares $1.29 billion +1.2%N/A11.4 $89.29
12/31/202414,320,000 shares $1.17 billion +13.7%N/A12.7 $81.86
12/15/202412,600,000 shares $1.11 billion +14.2%N/A11.4 $87.72
11/30/202411,030,000 shares $1.04 billion +13.8%N/A10.4 $94.34
11/15/20249,690,000 shares $841.38 million +8.5%N/A7.6 $86.83
10/31/20248,930,000 shares $949.71 million -4.4%N/A9.2 $106.35
10/15/20249,340,000 shares $1.08 billion -3.2%N/A10.2 $115.49
9/30/20249,650,000 shares $1.10 billion -0.6%N/A10 $114.27
9/15/20249,710,000 shares $1.13 billion -5.7%N/A9.4 $116.00
8/31/202410,300,000 shares $831.83 million -8.4%N/A10.4 $80.76
8/15/202411,240,000 shares $881.67 million -2.3%N/A15.9 $78.44
7/31/202411,500,000 shares $907.24 million -3.1%N/A15.4 $78.89
7/15/202411,870,000 shares $999.10 million +15.5%N/A16.2 $84.17
6/30/202410,280,000 shares $776.24 million +6.2%N/A14.6 $75.51
6/15/20249,680,500 shares $706.10 million +0.8%N/A14.9 $72.94
5/31/20249,600,000 shares $674.59 million +0.8%N/A15.3 $70.27
5/15/20249,520,000 shares $681.92 million +12.9%N/A13.7 $71.63
4/30/20248,430,000 shares $510.44 million +2.3%N/A11.7 $60.55
4/15/20248,240,000 shares $514.09 million -0.2%N/A9.7 $62.39
3/31/20248,260,000 shares $564.24 million -3.8%N/A9.6 $68.31
3/15/20248,590,000 shares $598.72 million +1.5%N/A9.9 $69.70
2/29/20248,460,000 shares $624.52 million -20.6%N/A9.3 $73.82
2/15/202410,650,000 shares $798.86 million +19.7%N/A12.3 $75.01
1/31/20248,900,000 shares $635.64 million +6.5%N/A10.7 $71.42
1/15/20248,360,000 shares $507.62 million +9.7%N/A12.4 $60.72
12/31/20237,620,000 shares $478.54 million +3.7%N/A11.6 $62.80
12/15/20237,350,000 shares $445.12 million +3.8%N/A11.6 $60.56
11/30/20237,080,000 shares $366.53 million -2.6%N/A11.5 $51.77
11/15/20237,270,000 shares $369.32 million -0.8%N/A12.6 $50.80
10/31/20237,330,000 shares $352.57 million +6.2%N/A12.7 $48.10
10/15/20236,900,000 shares $317.40 million -4.2%N/A12.8 $46.00
9/30/20237,200,000 shares $367.06 million -9.1%N/A13.5 $50.98
9/15/20237,920,000 shares $409.62 million +4.9%N/A14.9 $51.72
8/31/20237,550,000 shares $392.00 million -2.6%N/A13.9 $51.92
8/15/20237,750,000 shares $368.05 million +3.6%N/A13.6 $47.49
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
7/31/20237,480,000 shares $359.49 million -0.1%N/A12.3 $48.06
7/15/20237,490,000 shares $371.80 million +0.4%N/A10.2 $49.64
6/30/20237,460,000 shares $372.55 million +8.4%N/A8.1 $49.94
6/15/20236,880,000 shares $358.72 million -2.7%N/A7.2 $52.14
5/31/20237,070,000 shares $350.11 million +4.0%N/A7.5 $49.52
5/15/20236,800,000 shares $342.45 million +3.8%N/A7 $50.36
4/30/20236,550,000 shares $280.54 million -7.1%N/A7 $42.83
4/15/20237,050,000 shares $257.33 million +17.3%N/A8.1 $36.50
3/31/20236,010,000 shares $225.25 million +6.0%N/A8.8 $37.48
3/15/20235,670,000 shares $220.56 million +14.8%N/A8.3 $38.90
2/28/20234,940,000 shares $202.39 million +4.7%N/A7 $40.97
2/15/20234,720,000 shares $203.67 million +1.5%N/A6.6 $43.15
1/31/20234,650,000 shares $210.88 million +5.9%N/A6 $45.35
1/15/20234,390,000 shares $195.88 million -2.0%N/A3.3 $44.62
12/30/20224,480,000 shares $214.82 million +30.2%N/A3.4 $47.95
12/15/20223,440,000 shares $156.45 million +3.6%N/A2.6 $45.48
11/30/20223,320,000 shares $152.92 million -8.8%N/A2.7 $46.06
11/15/20223,640,000 shares $160.31 million -12.3%N/A3.1 $44.04
10/31/20224,150,000 shares $180.98 million +29.7%N/A3.7 $43.61
10/15/20223,200,000 shares $78.59 million +29.0%8.2%4.2 $24.56
9/30/20222,480,000 shares $59.52 million +22.8%6.3%5.7 $24.00
9/15/20222,020,000 shares $57.00 million +10.4%5.2%5.1 $28.22
8/31/20221,830,000 shares $47.87 million -12.9%4.7%4.8 $26.16
8/15/20222,100,000 shares $54.68 million +4.5%5.4%5.5 $26.04
7/31/20222,010,000 shares $46.39 million -1.0%5.3%5.4 $23.08
7/15/20222,030,000 shares $50.53 million +9.7%5.4%5.6 $24.89
6/30/20221,850,000 shares $40.26 million +11.5%4.9%5 $21.76
6/15/20221,660,000 shares $31.04 million -18.2%4.4%4.4 $18.70
5/31/20222,030,000 shares $48.70 million +2.0%5.4%6.3 $23.99
5/15/20221,990,000 shares $46.82 million +4.2%5.3%7 $23.53
4/30/20221,910,000 shares $46.24 million +2.7%5.2%6.9 $24.21
4/15/20221,860,000 shares $45.63 million -6.5%5.0%6.6 $24.53
3/31/20221,990,000 shares $48.06 million -0.5%5.6%6.3 $24.15
3/15/20222,000,000 shares $49.78 million -1.5%5.6%6.9 $24.89
2/28/20222,030,000 shares $47.04 million +9.7%5.7%7 $23.17
2/15/20221,850,000 shares $38.31 million +12.8%5.3%6.4 $20.71
1/31/20221,640,000 shares $31.23 million +28.1%5.1%6.2 $19.04
1/15/20221,280,000 shares $24.87 million +14.3%4.0%5.5 $19.43
12/31/20211,120,000 shares $26.64 million -21.7%3.7%7 $23.79
12/15/20211,430,000 shares $32.02 million +26.6%4.7%9.5 $22.39
11/30/20211,130,000 shares $23.03 million -7.4%3.8%7.5 $20.38
11/15/20211,220,000 shares $31.82 million -6.9%4.1%8.1 $26.08
10/29/20211,310,000 shares $30.65 million +2.3%4.5%8 $23.40
10/15/20211,280,000 shares $31.24 million -9.9%4.3%7.8 $24.41
9/30/20211,420,000 shares $36.03 million -20.7%4.8%8.4 $25.37
9/15/20211,790,000 shares $47.35 million -23.5%6.1%9 $26.45
8/31/20212,340,000 shares $61.38 million -17.6%8.0%11.2 $26.23
8/13/20212,840,000 shares $73.93 million +1.8%9.8%13.2 $26.03
7/30/20212,790,000 shares $60.49 million -6.4%9.8%13.1 $21.68
7/15/20212,980,000 shares $61.06 million -2.9%10.2%13.3 $20.49
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
6/30/20213,070,000 shares $69.11 million -13.0%10.5%12.5 $22.51
6/15/20213,530,000 shares $77.94 million -1.1%12.1%13.3 $22.08
5/28/20213,570,000 shares $75.22 million -4.3%12.2%11.4 $21.07
5/14/20213,730,000 shares $71.21 million No Change12.8%10.8 $19.09
4/30/20213,730,000 shares $69.97 million -1.1%13.2%9.1 $18.76
4/15/20213,770,000 shares $75.02 million -21.1%13.3%9 $19.90
3/31/20214,780,000 shares $89.19 million +27.1%17.0%11.3 $18.66
3/15/20213,760,000 shares $99.19 million -0.5%13.5%9 $26.38
2/26/20213,780,000 shares $95.26 million +12.5%13.6%10.2 $25.20
2/12/20213,360,000 shares $86.89 million +3.7%12.1%9.1 $25.86
1/29/20213,240,000 shares $78.15 million +6.2%11.1%10 $24.12
1/15/20213,050,000 shares $78.78 million No Change10.5%11 $25.83

PCVX Short Interest - Frequently Asked Questions

What is Vaxcyte's current short interest?

Short interest is the volume of Vaxcyte shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 12,050,000 shares of PCVX short. 9.98% of Vaxcyte's shares are currently sold short. Learn More on Vaxcyte's current short interest.

What is a good short interest ratio for Vaxcyte?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCVX shares currently have a short interest ratio of 7.0. Learn More on Vaxcyte's short interest ratio.

Which institutional investors are shorting Vaxcyte?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vaxcyte: Toronto Dominion Bank, Torno Capital LLC, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Boothbay Fund Management LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., JPMorgan Chase & Co., Twin Tree Management LP, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Vaxcyte?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.98% of Vaxcyte's floating shares are currently sold short.

Is Vaxcyte's short interest increasing or decreasing?

Vaxcyte saw a decline in short interest in March. As of March 31st, there was short interest totaling 12,050,000 shares, a decline of 4.4% from the previous total of 12,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Vaxcyte's short interest compare to its competitors?

9.98% of Vaxcyte's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vaxcyte: Teva Pharmaceutical Industries Limited (2.87%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S (0.34%), Dr. Reddy's Laboratories Limited (1.82%), Ascendis Pharma A/S (11.84%), Moderna, Inc. (14.58%), Viatris Inc. (3.86%), Qiagen (1.88%), Roivant Sciences Ltd. (10.28%), Lantheus Holdings, Inc. (9.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Vaxcyte stock?

Short selling PCVX is an investing strategy that aims to generate trading profit from Vaxcyte as its price is falling. PCVX shares are trading up $1.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vaxcyte?

A short squeeze for Vaxcyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCVX, which in turn drives the price of the stock up even further.

How often is Vaxcyte's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCVX, twice per month. The most recent reporting period available is March, 31 2025.




This page (NASDAQ:PCVX) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners